Control Crohn Safe Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

May 31, 2024

Study Completion Date

September 30, 2026

Conditions
Crohn DiseaseInflammatory Bowel Diseases
Interventions
DRUG

Adalimumab

episodic treatment with subcutaneous adalimumab for 6 months

DRUG

standard step-up care

conventional step-up care starting with corticosteroids

Trial Locations (6)

Unknown

RECRUITING

Maastricht University Medical Centre+, Maastricht

RECRUITING

St. Antonius Ziekenhuis, Nieuwegein

RECRUITING

Laurentius Ziekenhuis, Roermond

RECRUITING

Zuyderland Medical Center, Sittard

RECRUITING

Máxima Medisch Centrum, Veldhoven

RECRUITING

VieCuri, Venlo

All Listed Sponsors
collaborator

Maastricht University

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Maastricht University Medical Center

OTHER